Clinical trials are essential for developing healthcare treatments. We contribute to the development by sourcing pharmaceuticals used as comparators and co-medications in clinical trials.

Based on the free movement of goods and services within the EU, we import original pharmaceuticals marketed in EU countries, repack and relabel these, and resell the products on different markets at more affordable prices for the end-users and societies.

Sometimes, the needed treatment isn't available with a traditional marketing authorization in the patient's country. To support these patients, we deliver treatment through special authorization from local authorities. This is known as Unlicensed Medicine.

Clinical trials are essential for developing healthcare treatments. We contribute to the development by sourcing pharmaceuticals used as comparators and co-medications in clinical trials.

Based on the free movement of goods and services within the EU, we import original pharmaceuticals marketed in EU countries, repack and relabel these, and resell the products on different markets at more affordable prices for the end-users and societies.

Sometimes, the needed treatment isn't available with a traditional marketing authorization in the patient's country. To support these patients, we deliver treatment through special authorization from local authorities. This is known as Unlicensed Medicine.

Clinical trials are essential for developing healthcare treatments. We contribute to the development by sourcing pharmaceuticals used as comparators and co-medications in clinical trials.

Based on the free movement of goods and services within the EU, we import original pharmaceuticals marketed in EU countries, repack and relabel these, and resell the products on different markets at more affordable prices for the end-users and societies.

Sometimes, the needed treatment isn't available with a traditional marketing authorization in the patient's country. To support these patients, we deliver treatment through special authorization from local authorities. This is known as Unlicensed Medicine.

Clinical trials are essential for developing healthcare treatments. We contribute to the development by sourcing pharmaceuticals used as comparators and co-medications in clinical trials.

Based on the free movement of goods and services within the EU, we import original pharmaceuticals marketed in EU countries, repack and relabel these, and resell the products on different markets at more affordable prices for the end-users and societies.

Sometimes, the needed treatment isn't available with a traditional marketing authorization in the patient's country. To support these patients, we deliver treatment through special authorization from local authorities. This is known as Unlicensed Medicine.